Empagliflozin vs Ondansetron
Empagliflozin vs Ondansetron: Overview
This comparison examines the pharmacological differences between Empagliflozin and Ondansetron.
Mechanism of Action
Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.
Ondansetron: Selective 5-HT3 receptor antagonist.
Pharmacokinetics
Half-life: Empagliflozin β 12.4 hours; Ondansetron β 3-5 hours.
Chemical Properties
Molecular Formula: Empagliflozin β C23H27ClO7; Ondansetron β C18H19N3O.
Molecular Weight: Empagliflozin β 450.9100 g/mol; Ondansetron β 293.3660 g/mol.
Type: Empagliflozin β Small molecule; Ondansetron β Small molecule.